Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Arab Emirates
  4. Abu Dhabi Securities Exchange
  5. Abu Dhabi Islamic Bank PJSC
  6. News
  7. Summary
    ADIB   AEA000801018

ABU DHABI ISLAMIC BANK PJSC

(ADIB)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Abu Dhabi Islamic Bank : ADIB launches second tranche of Healthcare Pharmaceuticals Equities Basket Note following popular demand

07/11/2017 | 11:59am EDT

ADIB launches second tranche of Healthcare Pharmaceuticals Equities Basket Note following popular demand

UAE, Abu Dhabi, 8 July 2017 -Abu Dhabi Islamic Bank (ADIB), a leading financial institution, has launched a second tranche of its Healthcare Pharmaceuticals Equities Basket Note following popular demand from customers and investors on the first tranche that was launched in May 2017. Designed to capitalise on projected growth in the healthcare industry, the Shariah-compliant note matures in one year and provides 100% capital protection at maturity to minimise investment risk.

The product provides investors with exposure to a basket of leading international companies operating across the healthcare and pharmaceutical sectors, including Pfizer, Merck, Celgene, Novartis and Novo Nordisk. The note is open for subscription until August 24, 2017 and offers a 3-month lock-in period. The minimum investment for the note, which has a maturity date of August 30, 2018, is US$30,000.

Daffer Luqman, Global Head of Liabilities and Wealth Management at ADIB, said: 'We continue to see strong demand for ADIB's Shariah-compliant equity basket notes as investors appreciate the opportunity to attain strong returns in a low return environment with no risk to their capital. Global healthcare is a growth industry due to aging demographics in developed economies and increases in population and wealth in emerging markets. This note provides exposure to leading international pharmaceutical companies primed to capitalise on such demographic and economic trends. As a bank, we will continue to develop tailored wealth management solutions to customers which allow them to meet their financial goals through a diversified investment portfolio.'

ADIB continues to develop and deliver best-in-class solutions tailored to meet the financial needs of customers through effective financial planning and asset allocation.
On June 5, 2017, an ADIB Shariah-compliant equity note capturing the performance of blue-chip German exporters yielded 5.46% upon its maturity.

Abu Dhabi Islamic Bank PJSC published this content on 09 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 July 2017 15:59:11 UTC.


© Publicnow 2017
All news about ABU DHABI ISLAMIC BANK PJSC
2020ABU DHABI ISLAMIC BANK  : Investment Office to open Tel Aviv office
RE
2020ABU DHABI ISLAMIC BANK  : Investment Office to open Tel Aviv office
RE
2020UAE's top banks reveal exposure to troubled hospital group NMC Health
RE
2019Sudan's bourse maps out expansion plans amid uncertainty
RE
2019First Abu Dhabi Bank, Abu Dhabi Islamic Bank deny merger talks
RE
2018Growing Islamic finance firms lobby Britain for tax relief
RE
2017Britain plans new sukuk deal; Brexit may boost Islamic finance
RE
2017ABU DHABI ISLAMIC BANK  : ADIB hosts EFICA roundtable on enhancing Fintech's rol..
PU
2017ABU DHABI ISLAMIC BANK  : ADIB named ‘Islamic Bank of the Year – UAE..
PU
2017ABU DHABI ISLAMIC BANK  : ADIB launches second tranche of Healthcare Pharmaceuti..
PU
More news
Financials
Sales 2021 5 192 M 1 414 M 1 414 M
Net income 2021 1 075 M 293 M 293 M
Net Debt 2021 - - -
P/E ratio 2021 16,5x
Yield 2021 1,21%
Capitalization 18 015 M 4 904 M 4 905 M
Capi. / Sales 2021 3,47x
Capi. / Sales 2022 3,25x
Nbr of Employees 0
Free-Float 52,9%
Chart ABU DHABI ISLAMIC BANK PJSC
Duration : Period :
Abu Dhabi Islamic Bank PJSC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABU DHABI ISLAMIC BANK PJSC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 5,40 AED
Last Close Price 4,96 AED
Spread / Highest target 16,9%
Spread / Average Target 8,87%
Spread / Lowest Target 0,81%
EPS Revisions
Managers and Directors
NameTitle
Mohamed Abdel Bary Group Chief Financial Officer
Jawaan Awaidha Suhail Al-Khaili Chairman
Mamoun T. Al-Homssey Chief Information Officer
Hassan Adel Khalifa Operations Head
Adel Ahmed Al-Zarouni General Manager-Real Estate & Administration
Sector and Competitors